Title |
No. |
Epstein–Barr virus molecular epidemiology and variants identification in head and neck squamous cell carcinoma |
1 |
Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran |
2 |
COVID-19 in the endoscopy ward: A potential risk for gastroenterologists |
3 |
Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study |
4 |
Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study |
5 |
10-year risk of cardiovascular disease and body mass index in association with the obesity paradox |
6 |
SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran |
7 |
Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19? |
8 |
SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial |
9 |
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatment |
10 |
Are there any association between COVID-19 severity and immunosuppressive therapy? (Comment) |
11 |
Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes |
12 |
Health related quality of life in patient with type 2 diabetes: The role of household food insecurity on latent class membership |
13 |
The effects of ginger supplementation on biomarkers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials |
14 |
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment |
15 |
Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - A comprehensive review from chemotherapy to immunotherapy |
16 |
Repositioning of the global epicentre of non-optimal cholestero |
17 |
Preventive strategies used by GI physicians during the COVID-19 pandemic |
18 |
The incidence and risk factors of non-alcoholic fatty liver disease: A cohort study from Iran |
19 |
Radioprotective effects of montelukast, a selective leukotriene CysLT1 receptor antagonist, against nephrotoxicity induced by gamma radiation in mice |
20 |
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma |
21 |
Hospital Facilities at Home for Heart Failure Patients |
22 |
Mental health advice for frontline healthcare providers caring for patients with COVID-19 |
23 |
Evaluating the Relation between Serum Zinc Level and Severity and Complications of Cirrhosis |
24 |
A Case Report of Progressive Dysphagia and Pigmented Oral and Skin Lesions: Esophageal Lichen Planus |
25 |
Molecular Epidemiology of Epstein-Barr virus (EBV) in Patients with Hematologic Malignancies |
26 |
Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection |
27 |
Molecular Epidemiology of Anellovirus Infection in Children's Urine: A Cross-sectional Study |
28 |
Can COVID-19 present unusual GI symptoms? |
29 |
Can Increasing the Number of Close Contact Lead to More Mortality in COVID-19 Infected Patients? |
30 |
Dysentery as a rare GI symptom found in COVID-19 patients (Case Reports) |
31 |
Esophageal Polyp Lesion in a Patient with Globus Pharyngeus Compliant (Case Reports) |
32 |
Dysentery as a rare GI symptom found in COVID-19 patients |
33 |
Esophageal Polyp Lesion in a Patient with Globus Pharyngeus Compliant |
34 |
The role of transcranial sonography in differentiation of dementia subtypes: an introduction of a new diagnostic method |
35 |
Relationship between household food insecurity and food and nutrition literacy among children of 9-12 years of age: a cross-sectional study in a city of Iran |
36 |
The Molecular Epidemiology of Herpes Simplex Virus Type 1 and 2 (HSV-1 and HSV-2) in Head and Neck Cancer (HNC) |
37 |
38 |
|
Investigation of JC Polyomavirus (JCV) Genome in Colorectal Cancer Patients from Iran |
39 |
Pivotal Role of Peptides in Gastric Carcinoma: Diagnosis and Therapy |
40 |
41 |
|
Severe Post-ERCP Pancreatitis Following Pancreatic Duct Stenting for Needle Knife Common Bile Duct Cannulation: a Case Series and Review of Literature |
42 |
Gastrointestinal presentation in a patient with COVID-19 without respiratory tract symptoms: A case report from Qom, Iran |
43 |
The Equal Danger of Improper Use of Face Mask and Use of Improper Mask |
44 |
Automatic reduction of wireless capsule endoscopy reviewing time based on factorization analysis |
45 |
Nutrition labels' strengths & weaknesses and strategies for improving their use in Iran: A qualitative study |
46 |
Development and validation of food and nutrition literacy assessment tool for iranian high-school graduates and youth |
47 |
Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis |
48 |
Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial |
49 |
A comparative study of the effect of 10-day esomeprazole containing levofloxacin versus clarithromycin sequential regimens on the treatment of Iranian patients with Helicobacter pylori infection |
50 |
Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial |
51 |
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial |
52 |
Subepithelial Lesion in Bulb with Gastric Outlet Obstruction |
53 |
تهران، بیمارستان فیروزگر، مرکز تحقیقات بیماریهای گوارش و کبد دانشگاه علوم پزشکی ایران
پست الکترونیکی: gildrc /AT/ iums.ac.ir
تلفن و دورنگار مرکز : 88941831
مرکز تلفن دانشگاه : ۸۶۷۰۱-۰۲۱
کلیه حقوق این وب سایت متعلق به مرکز تحقیقات بیماریهای گوارش و کبد دانشگاه علوم پزشکی ایران می باشد.
طراحی و برنامه نویسی : یکتاوب افزار شرق
© 2018 All Rights Reserved | Gastrointestinal and Liver Diseases Research Center
Designed & Developed by : Yektaweb